Cushing's disease in childhood as the first manifestation of multiple endocrine neoplasia syndrome type 1

European Journal of Endocrinology

Volumn 151, Issue 6, 2004, Pages 709-715

  Rix, Mariane ^a   Hertel, N T ^b   Nielsen, F C ^c   Jacobsen, B B ^b   Hoejberg, A S ^a   Brixen, K ^b   Hangaard, J ^d   Kroustrup, J P ^a  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c Rigshospitalet   (Denmark)

^d SVENDBORG HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; DNA; FOLLITROPIN; GROWTH HORMONE; HISTIDINE; HYDROCORTISONE; LEUCINE; LUTEINIZING HORMONE; PARATHYROID HORMONE; PROLINE; TYROSINE;

ADOLESCENT; ARTICLE; CASE REPORT; CHILD; CLINICAL FEATURE; CUSHING DISEASE; ENDOCRINE SURGERY; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC SCREENING; GROWTH RETARDATION; HORMONE SUBSTITUTION; HOSPITAL ADMISSION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOPHYSIS ADENOMA; MALE; MONOZYGOTIC TWINS; MULTIPLE ENDOCRINE NEOPLASIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; WEIGHT GAIN;

ADENOMA; ADOLESCENT; ADRENOCORTICOTROPIC HORMONE; CHILD; CUSHING SYNDROME; DEXAMETHASONE; DNA MUTATIONAL ANALYSIS; FEMALE; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; HYPERPARATHYROIDISM; MAGNETIC RESONANCE IMAGING; MALE; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; OBESITY; PITUITARY NEOPLASMS; TWINS;

EID: 11844306569     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1510709     Document Type: Article

References (36)

1. Trump D, Farren B, Wooding C, Pang JT, Besser GM, Buchanan K, Edwards CR, Heath DA, Jackson CE, Jansen S, Lips K, Monson JP, O'Halloran D, Sampson J, Shalet SM, Wheeler MH, Zink A & Thakker RV. Clinical studies of multiple endocrine neoplasia. type 1 (MEN1). Quarterly Journal of Medicine 1996 89 653-669.
2. Chandrasekharappa SC, Guru SC, Manickam P, Olufemi SE, Collins FS, Emmert-Buck MR, Debelenko LV, Zhuang Z, Lubensky IA, Liotta LA, Crabtree JS, Wang Y, Roe BA, Weisemann J, Boguski MS, Agarwal SK, Kester MB, Kim YS, Heppner C, Dong Q, Spiegel AM, Burns AL & Marx SJ. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 1997 276 404-407.
3. Kim H, Lee JE, Cho EJ, Liu JO & Youn HD. Menin, a tumor suppressor, represses JunD-mediated transcriptional activity by association with an mSin3A-histone deacetylase complex. Cancer Research 2003 63 6135-6139.
4. Marx SJ & Nieman LK. Aggressive pituitary tumours in MEN1: do they refute the two-hit model of tumorigenesis? Journal of Clinical Endocrinology and Metabolism 2002 87 453-456.
5. Chandrasekharappa SC & Teh BT. Functional studies of the MEN1 gene. Journal of Internal Medicine 2003 253 606-615.
6. Bassett JH, Forbes SA, Pannett AA, Lloyd SE, Christie PT, Wooding C, Harding B, Besser GM, Edwards CR, Monson JP, Sampson J, Wass JA, Wheeler MH & Thakker RV. Characterization of mutation in patient with multiple endocrine neoplasia type 1. American Journal of Human Genetics 1998 62 232-244.
7. Waterlot C, Porchet N, Bauters C, Decoulx M, Wemeau JL, Proye C, Degand PM, Aubert JP, Cortet C & Dewailly D. Type 1 multiple endocrine neoplasia. (MEN1): contribution of genetic analysis to the screening and follow-up of a large French kindred. Clinical Endocrinology (Oxford) 1999 51 101-107.
8. Geerdink EAM, Van der Luijt RB & Lips CJM. Do patients with multiple endocrine neoplasia syndrome type 1 benefit from periodical screening? European Journal of Endocrinology 2003 149 577-582.
9. Verges B, Boureille F, Goudet P, Murat A, Beckers A, Sassolas G, Cougard P, Chambe B, Montvernay C & Calender A. Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study. Journal of Clinical Endocrinology and Metabolism 2002 87 457-465.
10. Veldhuis JD, Norton JA, Wells SA, Vinik AI & Perry RR. Therapeutic controversy. Surgical versus medical management of multiple endocrine neoplasia (MEN) type 1. Journal of Clinical Endocrinology and Metabolism 1997 82 357-364.
11. Burgess JR, Nord B, David R, Greenway TM, Parameswaran V, Larsson C, Shepherd JJ & Teh BT. Phenotype and phenocopy: the relationship between genotype and clinical phenotype in a single large family with multiple endocrine neoplasia type 1 (MEN1). Clinical Endocrinology 2000 53 205-211.
12. Skogseid B, Eriksson B, Lundquist G, Lörelius E, Rastad J, Åkerström G & Oberg K. Multiple endocrine neoplasia type 1: a 10-year prospective screening study in four kindreds. Journal of Clinical Endocrinology and Metabolism 1991 73 281-287.
13. Vasen HFA, Lamers CBHW & Lips CJM. Screening for the multiple endocrine neoplasia syndrome type 1. A study of 11 kindreds in the Netherlands. Archives of Internal Medicine 1989 149 2717-2722.
14. Beckers A, Betea D, Valdes Socin H & Stevenaert A. The treatment of sporadic versus MEN1-related pituitary adenomas. Journal of Internal Medicine 2003 253 599-605.
15. Burgess JR, Shepherd JJ, Parameswaran V, Hoffman L & Greenaway TM. Spectrum of pituitary disease in multiple endocrine neoplasia type 1 (MEN1): clinical, biochemical, and radiological features of pituitary disease in a large MEN1 kindred. Journal of Clinical Endocrinology and Metabolism 1996 81 2642-2646.
16. Gaitan D, Loosen PT & Orth DN. Two patients with Cushing's disease in a kindred with multiple endocrine neoplasia type 1. Journal of Clinical Endocrinology and Metabolism 1993 76 1580-1581.
17. Oldfield EH, Doppman JL, Nieman LK, Chrousos GP, Miller DL, Katz DA, Cutler GB Jr & Loriaux DL. Petrosal sinus sampling with and without corticotropin-releasing hormone for differential diagnosis of Cushing's syndrome. New England Journal of Medicine 1991 325 897-905.
18. Aron CA, Raff H & Findling JW. Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism 1996 82 1780-1785.
19. Isidori AM, Kaltsas GA, Mohammed S, Morris DG, Jenkins P, Chew SL, Monson JP, Besser GM & Grossman AB. Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism 2003 88 5299-5306.
20. Cetani F, Pardi E, Cianferotti L, Vignali E, Picone A, Micolli P, Pinchera A & Marcocci C. A new mutation of MEN1 gene in an Italian kindred with multiple endocrine neoplasia type 1. European Journal of Endocrinology 1999 140 429-433.
21. Marx S, Spiegel AM, Skarulis MC, Doppman JL, Collins FS & Liotta LA. Multiple endocrine neoplasia type 1: clinical and genetic topics. Annals of Internal Medicine 1998 129 484-494.
22. Stratakis CA, Schussheim DH, Freedman SM, Keil MF, Pack SD, Agarwal SK, Skarulis MC, Weil RJ, Lubensky IA, Zhuang Z, Oldfield EH & Marx SJ. Pituitary macroadenoma in a 5-year-old: an early expression of multiple endocrine neoplasia type 1. Journal of Clinical Endocrinology and Metabolism 2000 85 4776-4780.
23. Kontogeorgos G, Kapranos N, Tzavara I, Thalaassinos N & Rologis D. Monosomy of chromosome 11 in pituitary adenoma in a patient with familial multiple endocrine neoplasia type 1. Clinical Endocrinology 2001 54 117-120.
24. Brandi ML, Gagel RF, Angeli A, Bilezikian JP, Beck-Peccoz P, Bordi C, Conte-Devolx B, Falchetti A, Gheri RG, Libroia A, Lips CJ, Lombardi G, Mannelli M, Pacini F, Ponder BA, Raue F, Skogseid B, Tamburrano G, Thakker RV, Thompson NW, Tomassetti P, Tonelli F, Wells SA Jr & Marx SJ. Consensus: guidelines for diagnosis and therapy of MEN type 1 and type 2. Journal of Clinical Endocrinology and Metabolism 2001 86 5658-5671.
25. Johnston LB, Chew SL, Trainer PJ, Reznek R, Grossman AB, Besser GM et al. Screening children at risk of developing inherited endocrine neoplasia syndromes. Clinical Endocrinology 2000 52 127-136.
26. Johnston LB, Chew D, Lowe D, Reznek R, Monsom JP & Savage MO. Investigating familial endocrine neoplasia syndromes in children. Hormone Research 2001 55 31-35.
27. Moshang T. Cushing's disease, 70 years later and the beat goes on. Journal of Clinical Endocrinology and Metabolism 2003 88 31-33.
28. Lindholm J, Juul S, Jorgensen JO, Astrup J, Bjerre P, Feldt-Rasmussen U, Hagen C, Jorgensen J, Kosteljanetz M, Kristensen L, Laurberg P, Schmidt K & Weeke J. Incidence and late prognosis of Cushing's syndrome: a population-based study. Journal of Clinical Endocrinology and Metabolism 2001 86 117-123.
29. Magiakou MA, Mastorakos G, Oldfield EH, Gomez MT, Doppman JL, Cutler GB Jr, Nieman LK & Chrousos GP. Cushing's syndrome in children and adolescents. New England Journal of Medicine 1994 331 629-636.
30. Storr HL, Plowman PN, Carroll PV, Francois I, Krassas GE, Afshar F, Besser GM, Grossman AB & Savage MO. Clinical and endocrine responses to pituitary radiotherapy in pediatric Cushing's disease: an effective secondline treatment. Journal of Clinical Endocrinology and Metabolism 2003 88 34-37.
31. Weber A, Trainer PJ, Grossman AB, Afshar F, Medbak S, Perry LA, Plowman PN, Rees LH, Besser GM & Savage MO. Investigation, management and therapeutic outcome in 12 cases of childhood and adolescent Cushing's syndrome. Clinical Endocrinology (Oxford) 1995 43 19-28.
32. Savage MO, Lienhardt A, Lebrethon MC, Johnston LB, Huebner A, Grossman AB, Afshar F, Plowman PN & Besser GM. Cushing's disease in childhood: presentation, investigation, treatment and long-term outcome. Hormone Research 2001 51 (Suppl 1) 24-30.
33. Devoe DJ, Miller WL, Conte FA, Kaplan SL, Grumbach MM, Rosenthal SM, Wilson CB & Gitelman SE. Long-term outcome in children and adolescents after transsphenoidal surgery for Cushing's disease. Journal of Clinical Endocrinology and Metabolism 1997 82 3196-3902.
34. Leinung MS, Kane LA, Scheithauer BW. Carpenter PC, Laws ER Jr & Zimmermann D. Long-term follow-up of transsphenoidal surgery for the treatment of Cushing's disease in childhood. Journal of Clinical Endocrinology and Metabolism 1995 80 2475-2479.
35. Massoud AF, Powel M, Williams RA, Hindmarsh PC & Brook CGD. Transsphenoidal surgery for pituitary tumours. Archives of Disease in Childhood 1997 76 398-404.
36. Lebrethon M-C, Grossman AB, Ashar F, Plowman N, Besser M & Savage MO. Linear growth and final height after treatment for Cushing's disease in childhood. Journal of Clinical Endocrinology and Metabolism 2000 85 3262-3265.